A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity
about
Dynamic Redox Regulation of IL-4 Signaling.The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancerPro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cellsCytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines.Genome-scale modeling of NADPH-driven β-lapachone sensitization in head and neck squamous cell carcinoma.Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells.Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?Mathematical and Computational Modeling in Complex Biological Systems.Biological Activities and Cytotoxicity of Eperua oleifera Ducke Oil-resin.Radiation-Sensitive Dendrimer-Based Drug Delivery System.
P2860
Q35839957-3254CAAD-7180-4389-A935-26BB1260EA29Q35862359-02014AB5-CBCF-485F-B919-0C929AC88090Q35915757-9E6C13D2-54F1-40F1-A9E9-FEF6A62E3361Q38241806-733F6C2D-50A2-45EA-8B4C-7115E9014DA5Q38576762-74FDB94D-A51C-49E7-91B3-30C30D19C715Q38649663-9AF63A56-CB06-4A4A-B6C7-DA74D56D7B78Q38697898-77AF848D-EDA1-4B85-B5B6-026A4953C6D2Q38831900-A42AB829-C588-4211-936C-948BDC69BBE3Q43153782-2D4B22EE-15F8-4BB7-AA7E-F3BA11CCDA33Q47148962-B1E02234-9ABD-49EB-9AF5-54B8378A52F8Q55007206-011DA3D7-A044-47B8-8993-063BD88FB097
P2860
A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A switching mechanism in doxor ...... o control doxorubicin toxicity
@ast
A switching mechanism in doxor ...... o control doxorubicin toxicity
@en
A switching mechanism in doxor ...... o control doxorubicin toxicity
@nl
type
label
A switching mechanism in doxor ...... o control doxorubicin toxicity
@ast
A switching mechanism in doxor ...... o control doxorubicin toxicity
@en
A switching mechanism in doxor ...... o control doxorubicin toxicity
@nl
prefLabel
A switching mechanism in doxor ...... o control doxorubicin toxicity
@ast
A switching mechanism in doxor ...... o control doxorubicin toxicity
@en
A switching mechanism in doxor ...... o control doxorubicin toxicity
@nl
P2093
P2860
P1476
A switching mechanism in doxor ...... o control doxorubicin toxicity
@en
P2093
Harry W Findley
Melissa L Kemp
Nnenna A Finn
P2860
P304
P356
10.1371/JOURNAL.PCBI.1002151
P407
P577
2011-09-01T00:00:00Z